Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Pfizer succeeds in Inlyta NICE appeal

04.03.2014 / Scripintelligence

NICE said: "Following the appeal process, NICE issued an updated scope and matrix to include sunitinib and pazopanib as comparators in addition to best supportive care for the post-cytokine sub-group, and the manufacturer of axitinib submitted more…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: